Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
4
×
cholesterol
inclisiran
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
praluent
4
×
regeneron pharmaceuticals
repatha
pcsk9
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ldl
medco
medicines co.
mt sinai hospital
national
new york
prashant vaishnava
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
What
cholesterol
4
×
drug
lowering
medco
medicines
twice
abbvie’s
aces
announced
barbecuing
big
bio
bringing
camping
cardiologist
center
ceo
check
clears
closer
conference
day
drugs
expensive
faces
fda
filing
financial
flexible
flop
foe
healthcare
hint
hit
inched
inclisiran
inhibitors
j
j’s
key
Language
unset
Current search:
praluent
×
cholesterol
×
" boston top stories "
×
" new york top stories "
×
@xconomy.com
5 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)